Tirzepatide vs Retatrutide
A dual-hormone medication available today vs an investigational triple-hormone agonist — compared by a physician.
Medically reviewed by Charles Kamen, MD, board-certified neurologist ·
Tirzepatide and retatrutide are both injectable medications studied for weight management, but they are at very different stages. Tirzepatide is FDA-approved and available now. Retatrutide is an investigational drug still in clinical trials — it is not yet FDA-approved or commercially available.
At LiveNow Longevity we prescribe only FDA-approved options after a complete medical evaluation. This page is educational and explains how the two differ; it is not medical advice, and we do not offer investigational drugs.
| Tirzepatide | Retatrutide | |
|---|---|---|
| Hormone pathways | GIP + GLP-1 (dual agonist) | GIP + GLP-1 + glucagon (triple agonist) |
| FDA status | FDA-approved (Mounjaro, Zepbound) | Investigational — not FDA-approved |
| Availability | Available now, when appropriate | In clinical trials; not commercially available |
| Administration | Once-weekly injection | Once-weekly injection (in trials) |
| How we decide | Prescribed after evaluation when appropriate | Not prescribed unless and until FDA-approved |
Bottom line: Tirzepatide is an FDA-approved, dual-hormone medication available today. Retatrutide adds a third hormone pathway (glucagon) and has shown promise in early trials, but it is investigational and not yet available. We work with FDA-approved options, chosen after a medical evaluation.
Frequently Asked Questions
Can I get retatrutide in Las Vegas?
Not yet. Retatrutide is an investigational drug still in clinical trials and is not FDA-approved or commercially available anywhere. We prescribe FDA-approved options, such as tirzepatide or semaglutide, when appropriate after evaluation.
What is the difference between tirzepatide and retatrutide?
Tirzepatide acts on two hormone pathways (GIP and GLP-1); retatrutide is designed to act on three (GIP, GLP-1, and glucagon). Tirzepatide is FDA-approved; retatrutide is still investigational.
Which is better for weight loss?
Retatrutide has shown promising results in early trials, but it is not yet available and long-term data are still being gathered. For patients today, the appropriate FDA-approved option is determined by Dr. Kamen after a medical evaluation.
How do I get started?
Book online or call (702) 808-2650 to schedule your evaluation in Las Vegas.
Physician-Led in Las Vegas
Which one is right for you?
That is a medical decision — and exactly what the $88 evaluation is for. Dr. Charles Kamen, MD reviews your labs, history, and goals and recommends the option that fits you.
Ready to start your longevity care?
Book your $88 evaluation with Dr. Kamen today, online, by phone, or by text.
Prefer to talk? Call (702) 808-2650 or text us to book.
Also serving Henderson — or explore semaglutide weight loss in Las Vegas.